All goodwill relates to the Food Distribution segment. Changes in the carrying amount of goodwill were as follows:

(In thousands)	Total
Balance at December 29, 2018:	$	178,648
Acquisitions		2,387
Balance at December 28, 2019 and January 2, 2021:	$	181,035

The Company reviews goodwill and other intangible assets for impairment annually, during the fourth quarter of each year, and more frequently if circumstances indicate the possibility of impairment. Testing goodwill and other intangible assets for impairment requires management to make significant estimates about the Company’s future performance, cash flows, and other assumptions that can be affected by potential changes in economic, industry or market conditions, business operations, competition, or the Company’s stock price and market capitalization.

During the Company’s 2020 annual impairment review, projected cash flows were discounted based on a weighted average cost of capital (“WACC”) of 10.3%. This WACC was developed from adjusted market based and company specific factors, current interest rates, equity risk premiums, and other market-based expectations regarding expected investment returns. The development of the WACC requires estimates of an equity rate of return and a debt rate of return, which are specific to the industry in which the Food Distribution reporting unit operates. The Company concluded that the fair value of the Food Distribution reporting unit was substantially in excess of its carrying value in the annual review.

The following table reflects the components of amortized intangible assets, included in “Intangible assets, net” on the consolidated balance sheets:

	January 2, 2021					December 28, 2019
	Gross					Gross
	Carrying			Accumulated		Carrying		Accumulated
(In thousands)	Amount			Amortization		Amount		Amortization
Non-compete agreements		$	4,287	$	2,075	$	4,438	$	1,493
Pharmacy customer prescription lists			4,233		1,521		8,200		4,481
Customer relationships			57,937		15,160		57,937		11,497
Trade names			1,068		837		1,068		687
Franchise fees and other			1,081		497		1,114		422
Total		$	68,606	$	20,090	$	72,757	$	18,580

The weighted average amortization periods for amortizable intangible assets as of January 2, 2021 are as follows:

Non-compete agreements

6.1 years

Pharmacy customer prescription lists

8.0 years

Customer relationships

16.4 years

Trade names

5.0 years

Franchise fees and other

10.0 years

Amortization expense for intangible assets was $5.7 million, $5.8 million and $5.8 million for 2020, 2019 and 2018, respectively.

Estimated amortization expense for each of the five succeeding fiscal years is as follows:

(In thousands)	2021					2022					2023					2024					2025
Amortization expense	$		5,202			$		4,849			$		4,807			$		4,556			$		4,159

The Company has indefinite-lived intangible assets that are not amortized, consisting primarily of indefinite-lived trade names and licenses for the sale of alcoholic beverages. During the third quarter of 2020, the Company made the decision to abandon a tradename within the Food Distribution segment to better integrate with the Company’s overall transportation operations, resulting in a $7.0 million impairment of the associated indefinite-lived tradename asset. During the fourth quarter of 2020, the Company recognized an impairment charge of $1.7 million, related to a tradename based on a change in the assumptions supporting fair value. Changes in the carrying amount of indefinite-lived intangible assets were as follows:

(In thousands)	Indefinite-lived Intangible Assets
Balance at December 29, 2018	$	69,751
Acquisitions		20,631
Impairment		(13,966	)
Disposals		(160	)
Balance at December 28, 2019		76,256
Impairment (Note 6)		(8,630	)
Balance at January 2, 2021	$	67,626